Brooklyn Fi, LLC Sellas Life Sciences Group, Inc. Put Options Transaction History
Brooklyn Fi, LLC
- $18.3 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SLS
# of Institutions
38Shares Held
6.68MCall Options Held
1.73MPut Options Held
95.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$3.03 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.19MShares$1.57 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA734KShares$968,2800.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il485KShares$640,6180.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$568,0850.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $27.1M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...